A verification study of the anti-obesity effects of the consumption of proanthocyanidins derived from Acacia Bark: a randomized, placebo-controlled, double-blind, parallel-group comparison study - A verification study of the anti-obesity effects of the consumption of proanthocyanidins derived from Acacia Bark

ORTHOMEDICO Inc.0 sites68 target enrollmentJanuary 31, 2023

Overview

No summary available.

Registry

who.int

Start Date

January 31, 2023

End Date

September 30, 2023

Last Updated

last year

Study Type

Interventional

Sex

All

Sponsor

•1\. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2\. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3\. Subjects currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4\. Subjects who have severe anemia 5\. Subjects who drink a large amount of alcohol or excessively smoke 6\. Subjects whose life rhythms are irregular due to working a late\-night shift or others 7\. Subjects who intensely exercise 8\. Subjects who use or take "Foods for Specified Health Uses," or "Foods with Functional Claims" in daily 9\. Subjects who are currently taking medications (including herbal medicines) and supplements 10\. Subjects who are allergic to medicines and/or the test food related products 11\. Subjects who are pregnant, lactating, or planning to become pregnant during this trial 12\. Subjects who suffer from COVID\-19 13\. Subjects who have been enrolled in other clinical trials within the last 28 days before the agreement to participate in this trial or plan to participate another trial during this trial 14\. Subjects who are judged as ineligible to participate in this study by the physician